Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell-Derived Cardiomyocytes to Elucidate Single-Cell Phenotype in Brugada Syndrome and Short QT Syndrome
| Institution | Ruprecht-Karls-Universität Heidelberg |
|---|---|
| Projektleiter | Ibrahim El-Battrawy |
| Standort | Heidelberg/Mannheim |
| Projektart | Shared Expertise (SE) |
| Fördersumme | € 21.268,56 |
| SE-Merkmal | SE-Partner |
| SE-Nummer | SE171 |
| Beginn | 01.01.2018 |
| Ende | 31.12.2018 |
| Partnerprojekte |
|
Förderkennzeichen
81X2500208
Projektnummer
1066